Stockscreener 앱 받기
13.72
0.43%
-0.1048
전일 마감가:
$13.82
열려 있는:
$13.7
하루 거래량:
85,413
Relative Volume:
0.16
시가총액:
$605.95M
수익:
$200.93M
순이익/손실:
$-18.91M
주가수익비율:
-31.04
EPS:
-0.4419
순현금흐름:
$-9.09M
1주 성능:
-6.46%
1개월 성능:
-9.71%
6개월 성능:
-15.69%
1년 성능:
-10.53%
1일 변동 폭
$13.25
$13.98
1주일 범위
$13.25
$14.61
52주 변동 폭
$12.49
$21.89
Si Bone Inc Stock (SIBN) Company Profile
명칭
Si Bone Inc
전화
(408) 207-0700
주소
471 EL CAMINO REAL, SUITE 101, SANTA CLARA, CA
Compare SIBN vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SIBN
Si Bone Inc
|
13.72 | 610.36M | 200.93M | -18.91M | -9.09M | -0.4419 |
|
ABT
Abbott Laboratories
|
110.09 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
342.26 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
88.89 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.85 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.50 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Si Bone Inc Stock (SIBN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-27 | 개시 | TD Cowen | Buy |
| 2024-08-06 | 재확인 | Needham | Buy |
| 2024-03-28 | 개시 | Piper Sandler | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-04-07 | 재개 | Cantor Fitzgerald | Overweight |
| 2021-06-08 | 개시 | Citigroup | Buy |
| 2021-03-09 | 재확인 | Needham | Buy |
| 2020-12-16 | 재확인 | Needham | Buy |
| 2020-08-04 | 재확인 | Needham | Buy |
| 2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-05-05 | 재확인 | Needham | Buy |
| 2020-02-19 | 개시 | Needham | Buy |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-12-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2018-11-12 | 개시 | BofA/Merrill | Buy |
| 2018-11-12 | 개시 | Canaccord Genuity | Buy |
| 2018-11-12 | 개시 | JMP Securities | Mkt Outperform |
| 2018-11-12 | 개시 | Morgan Stanley | Overweight |
모두보기
Si Bone Inc 주식(SIBN)의 최신 뉴스
Liquidity Mapping Around (SIBN) Price Events - Stock Traders Daily
American Century Companies Inc. Acquires 521,683 Shares of SiBone $SIBN - MarketBeat
Earnings Recap: Can SI BONE Inc disrupt its industryGap Up & Trade Opportunity Analysis Reports - baoquankhu1.vn
Will SI BONE Inc. stock deliver strong dividend growthJuly 2025 Chart Watch & High Win Rate Trade Tips - Naître et grandir
SIBN Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
First Eagle Investment Management LLC Has $7.13 Million Stock Position in SiBone $SIBN - MarketBeat
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026 - GlobeNewswire Inc.
SIBN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
SIBN PE Ratio & Valuation, Is SIBN Overvalued - Intellectia AI
SIBN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SIBN SEC FilingsSi-Bone 10-K, 10-Q, 8-K Forms - Stock Titan
Why (SIBN) Price Action Is Critical for Tactical Trading - Stock Traders Daily
SI-BONE, Inc. (SIBN) Stock Analysis: Strong Buy Ratings Signal 57.73% Potential Upside - DirectorsTalk Interviews
Smith+Nephew signs distribution agreement with SI-BONE - MedTech Intelligence
Aug Technicals: What is the next catalyst for SI BONE Inc2025 Year in Review & Growth Focused Entry Reports - baoquankhu1.vn
Spartan Medical Inc. and SI-BONE Inc. Proudly Announce New Partne - The National Law Review
Spartan Medical Inc. and SI-BONE Inc. Proudly Announce New Partnership to Expand Access For Veterans & Wounded Warriors - EIN Presswire
SI‑BONE (SIBN) Losses Narrow In Q4 And Test Bearish Narratives On Profit Path - simplywall.st
SI-BONE, Inc. (NASDAQ:SIBN) Q4 2025 Earnings Call Transcript - Insider Monkey
SI-Bone (SIBN) Submits Automatic Mixed Securities Shelf Filing - GuruFocus
Si-Bone files for mixed shelf size not disclosed - marketscreener.com
Si-Bone Files For Mixed Shelf Size Not Disclosed - TradingView
Si-Bone inks 50,000-square-foot lease in San Jose - The Business Journals
SI-BONE Q4 2025 slides: profitability milestone as revenue tops $200M - Investing.com South Africa
SI-BONE (NASDAQ: SIBN) files shelf to register common, preferred, debt and warrants - Stock Titan
SI-BONE (SIBN) 2025 10-K shows narrowing losses and $3.5B+ market - Stock Titan
TD Cowen Maintains Buy Rating for SIBN, Raises Price Target | SI - GuruFocus
Truist raises SI-BONE stock price target on strong quarter By Investing.com - Investing.com Australia
Truist raises SI-BONE stock price target on strong quarter - Investing.com Nigeria
SiBone (NASDAQ:SIBN) Shares Gap Up on Earnings Beat - MarketBeat
SI-BONE, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Truist Securities Adjusts Price Target on SI-BONE to $24 From $23, Maintains Buy Rating - marketscreener.com
SI-Bone: Early Profitability and 2026 Growth Catalysts Underpin Buy Rating and $22 Price Target - TipRanks
SI-BONE revenue up 15% to USD 56.3M in Q4 2025 - Medical Buyer
Smith+Nephew, SI-BONE partner to distribute iFuse TORQ portfolio - Yahoo Finance
SI-BONE Inc (SIBN) Q4 2025 Earnings Call Highlights: Record Reve - GuruFocus
SiBone Q4 2025 Earnings Call Transcript - MarketBeat
Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings Call Summary | Si-Bone(SIBN.US) Q4 2025 Earnings Conference - 富途牛牛
SI-BONE (SIBN) Q4 2025 Earnings Call Transcript - The Globe and Mail
SI-BONE Inc reports results for the quarter ended December 31Earnings Summary - TradingView
SiBone Q4 Earnings Call Highlights - Yahoo Finance
Smith & Nephew (SNN) Strengthens Portfolio with SI-Bone Agreemen - GuruFocus
Earnings call transcript: Si-Bone Q4 2025 reports strong revenue growth and EPS beat - Investing.com
SI-BONE (SIBN) Reports Solid Q4 Revenue and Projects Ongoing Gro - GuruFocus
Si-Bone: Q4 Earnings Snapshot - KVUE
SI-BONE Q4 Loss Narrows, Revenue Rises - marketscreener.com
Si-Bone: Fourth Quarter Financial Overview - Bitget
SI-BONE Inc. (SIBN) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
SiBone (NASDAQ:SIBN) Announces Earnings Results, Beats Estimates By $0.09 EPS - MarketBeat
SI-BONE Posts Record 2025 Results and Strong 2026 Outlook - TipRanks
Si Bone Inc (SIBN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.61%
1.47%
자본화:
|
볼륨(24시간):